Algésal Baume
Therapeutic Area Rheumatology
Principes actifs Diethylamine, Salicylic acid
Africa
High-quality medicines developed to meet the therapeutic needs of today and tomorrow.
For more than 30 years, PHARMA Développement has been developing, manufacturing, and marketing medications that meet the highest standards of quality, safety, and efficacy.
Supporting patients and healthcare professionals is at the heart of our commitment. Our portfolio spans several therapeutic areas, enabling us to offer solutions tailored to the needs of the French and international markets, in compliance with regulatory requirements and with a constant focus on innovation.
Since 1991, our pharmaceutical and industrial expertise has enabled us to develop reliable, accessible medications recognized for their quality, thereby helping to improve patients’ comfort and quality of life.
The list of medications varies by region and is therefore not the same from one geographic area to another. It is also subject to change over time.
-
Algésal Suractivé
Therapeutic Area Rheumatology
Principes actifs Diethylamine, Myrtecaine, Salicylic acid
DOLFLAM 1% Gel
Therapeutic Area Rheumatology
Principes actifs Diclofenac sodium
DOLFLAM 50 mg Film-coated tablets
Therapeutic Area Rheumatology
Principes actifs Diclofenac Potassium
IPROFENE 100 mg / 5 ml
Therapeutic Area Rheumatology
Principes actifs Ibuprofen
PREDNABENE 5 mg Tablets
Therapeutic Area Rheumatology
Principes actifs Prednisolone
PREDNABENE 15 mg / 5 ml – 100 ml
Therapeutic Area Rheumatology
Principes actifs Prednisolone
PREDNABENE 20 mg
Therapeutic Area Rheumatology
Principes actifs Prednisolone
CANDISTAT 1%
Therapeutic Area Urology
Principes actifs Clotrimazole
CANDISTAT V 1%
Therapeutic Area Urology
Principes actifs Clotrimazole
CANDISTAT V 2%
Therapeutic Area Urology
Principes actifs Clotrimazole
FERMET 20 mg
Therapeutic Area Urology
Principes actifs Tadalafil
Report
Do you wish to make a report?
In accordance with legal and regulatory obligations governing health and safety, you can report any adverse event (medicinal or cosmetic) or suspected quality defect related to the use of one of our products.
This information is crucial for the ongoing evaluation of our safety profile. Please submit your report: directly to our monitoring department via the contact form for medications; and/or via our telephone number +33 (0)3 86 20 21 64.